Pharmacokinetics and bioavailability of pembrolizumab with berahyaluronidase alfa for subcutaneous administration in participants with advanced or metastatic solid tumors: The phase 1 study 3475A-C18. - Cohen GL; Coetzee C; Walton CA; Reig Torras Ò; Chul Cho B; McAdam G; Rojas CI; Medina Rodríguez L; Papai Z; Chan SW; Rapoport BL; Caglevic C; et al. (European journal of cancer (Oxford, England : 1990), 2025)